openPR Logo
Press release

Immune Checkpoint Inhibitors Market 2019 Industry Overview with Top Leaders: Merck & Co., Merck KGaA, Novartis AG, Pfizer, AstraZeneca, Immutep Limited | Forecast Research till 2026

09-03-2019 11:45 AM CET | Health & Medicine

Press release from: Orian Research

Immune Checkpoint Inhibitors Market 2019-2026

Immune Checkpoint Inhibitors Market 2019-2026

Immune checkpoint inhibitor is a type of drug used in immunotherapy. Although traditional chemotherapeutic drugs remain the first-line option for treatment of most cancer types, targeted immune therapies are emerging as standard treatments for advanced-stage cancers. These drugs target cell surface checkpoint proteins to stimulate the recognition and destruction of cancer cells by the immune system.

The global immune checkpoint inhibitors market is segmented based on type, application, and region. Based on type, the market is classified into CTLA-4 inhibitor, PD-1 inhibitor, PD-L1 inhibitor, and others. Based on application, it is categorized as lung cancer, bladder cancer, melanoma, hodgkin lymphoma, and others. Based on region, it is studied across North America Europe, Asia-Pacific, South America and Middle East and Africa.

Get Sample copy of This Report @ https://www.orianresearch.com/request-sample/1244157

This report focuses on Immune Checkpoint Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immune Checkpoint Inhibitors market size by analyzing historical data and future prospect.

The key players profiled in the market include:-

AstraZeneca PLC.
Bristol-Myers Squibb Company
Eli Lilly and Company
Fortress Biotech, Inc.
Hoffmann-La Roche Ltd.
Immutep Limited
Merck & Co., Inc.
….

Global Immune Checkpoint Inhibitors Industry is spread across 121 pages, profiling 10 top companies and supported with tables and figures.

Inquire more or share questions if any before the purchase on this report @

https://www.orianresearch.com/enquiry-before-buying/1244157

On the basis of type, the market is split into:

CTLA-4 Inhibitor
PD-1 Inhibitor
PD-L1 Inhibitor
Other Types

On the basis of application, the market is split into:

Lung Cancer
Bladder Cancer
Melanoma
Hodgkin Lymphoma
Others

Target Audience:

Immune Checkpoint Inhibitors Manufacturers
Traders, Importers, and Exporters
Raw Material Suppliers and Distributors
Research and Consulting Firms
Government and Research Organizations
Associations and Industry Bodies

Order a Copy of Global Immune Checkpoint Inhibitors Market Report @ https://www.orianresearch.com/checkout/1244157

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
Manufacturers
Suppliers
Distributors
Government Body & Associations
Research Institutes

Table of Contents:-

1. Introduction
2. Research Methodology
3. Executive Summary

4. Global Immune Checkpoint Inhibitors Market Overview

4.1. Market Segmentation & Scope

4.2. Market Trends

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.2.4. Supply Chain Analysis

4.3. Global Immune Checkpoint Inhibitors Market - Porter's Five Forces Analysis

4.4. Global Immune Checkpoint Inhibitors Market - PESTEL Analysis

5. Global Immune Checkpoint Inhibitors Market, by Type

5.1. Global Immune Checkpoint Inhibitors Market, Size and Forecast, 2015-2026

5.2. Global Immune Checkpoint Inhibitors Market, by CTLA-4 Inhibitor, 2015-2026

5.2.1. Key driving factors, trends and opportunities

5.2.2. Market size and forecast, 2015-2026

5.3. Global Immune Checkpoint Inhibitors Market, by PD-1 Inhibitor, 2015-2026

5.3.1. Key driving factors, trends and opportunities

5.3.2. Market size and forecast, 2015-2026

5.4. Global Immune Checkpoint Inhibitors Market, by PD-L1 Inhibitor, 2015-2026

5.4.1. Key driving factors, trends and opportunities

5.4.2. Market size and forecast, 2015-2026

5.5. Global Immune Checkpoint Inhibitors Market, by Other Types, 2015-2026

5.5.1. Key driving factors, trends and opportunities

5.5.2. Market size and forecast, 2015-2026

6. Global Immune Checkpoint Inhibitors Market, by Application

And Continued…

Contact Us:-
Ruwin Mendez
Vice President – Global Sales & Partner Relations
Orian Research Consultants
US +1 (415) 830-3727| UK +44 020 8144-71-27
Email: info@orianresearch.com

About Us: -
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immune Checkpoint Inhibitors Market 2019 Industry Overview with Top Leaders: Merck & Co., Merck KGaA, Novartis AG, Pfizer, AstraZeneca, Immutep Limited | Forecast Research till 2026 here

News-ID: 1829205 • Views:

More Releases from Orian Research

Adaptive Optics Market Size, Competitive Analysis, Share, Forecast- 2019-2025
Adaptive Optics Market Size, Competitive Analysis, Share, Forecast- 2019-2025
The global adaptive optics market is projected to grow at a significant CAGR of 39.7% during the forecast period owing to the increasing application of adaptive optics in retinal imaging and ophthalmology to reduce the optical aberrations. The integration of adaptive optics converts an ophthalmoscope into a microscope, allowing visualization of and optical access to individual retinal cells in living human eyes. To learn more about this report request a
Supply Chain Analytics Market Size, Competitive Analysis, Share, Forecast- 2019-2025
Supply Chain Analytics Market Size, Competitive Analysis, Share, Forecast- 2019- …
The Global Supply Chain Analytics Market is estimated to grow at a significant CAGR during the forecast period 2019- 2025. The impact of e-commerce on retailers and manufacturers is driving a revolution in many sectors and business organization. This has led to the introduction of supply chain analytics solution, which offers mathematics, statistics, predictive modeling and machine-learning techniques to find meaningful patterns and knowledge regarding order, shipment and transactional data.
Laparoscopic Instruments Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Laparoscopic Instruments Market Size, Competitive Analysis, Share, Forecast- 201 …
The laparoscopic or minimally invasive surgery uses a special surgical instrument known as laparoscope to look inside the body and carry out certain procedures. The laparoscopic instruments market is projected to witness a steady growth rate during the forecast period 2018-2023. The rise in preference of minimal invasive method over invasive surgeries, the high prevalence of lifestyle-oriented diseases, high global expenditure on the laparoscopic market, increasing healthcare market in emerging
Fertility Drug Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Fertility Drug Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Infertility is one of the major issue now a day due to change in life style & cultural shift. There are various fertility drugs available in market for infertility related problems. Fertility drugs enhance the reproductive ability by improving quality of egg or sperms by increasing the levels of certain hormones in human body. The major factors that are responsible for the growth of fertility drug market are Change in

All 5 Releases


More Releases for Inhibitor

Advances in KRAS Inhibitor Development
The development of KRAS inhibitors has been a significant advancement in the field of oncology, offering new hope for patients with cancers driven by KRAS mutations. KRAS, a key gene involved in cell signaling, is frequently mutated in various cancers, including lung, colorectal, and pancreatic cancers. These mutations lead to uncontrolled cell growth and division, making KRAS a critical target for cancer therapy. Download Report: https://www.kuickresearch.com/report-kras-inhibitors-market-lumakras-sales-kras-drugs-market-kras-market-size Historically, KRAS was considered an undruggable target
Breakthroughs in KRAS Inhibitor Research
KRAS mutations have posed a significant challenge in oncology for decades, but recent breakthroughs in KRAS inhibitor research have sparked hope for new cancer therapies. KRAS is a key regulator of cell growth and survival, and its mutations are prevalent in various cancers, particularly lung, colorectal, and pancreatic cancers. Despite being one of the most sought-after targets, KRAS has been notoriously difficult to inhibit, earning the reputation of being "undruggable." Download
Checkpoint Inhibitor Refractory Cancer Market
Checkpoint Inhibitor Refractory Cancer Market Overview The global Checkpoint Inhibitor Refractory Cancer Market is poised for significant growth, anticipating a high CAGR during the forecast period from 2023 to 2030. Understanding Checkpoint Inhibitor Refractory Cancer Refractory cancer, which might not respond to treatments immediately or might develop resistance later, has driven significant growth and transformation in the global checkpoint inhibitor refractory cancer market. The interest of oncologists in the potential antitumor activity of
Fibroblast Growth Factor Receptor Inhibitor Market - Maximizing Therapeutic Pote …
Newark, New Castle, USA: The "Fibroblast Growth Factor Receptor Inhibitor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Fibroblast Growth Factor Receptor Inhibitor Market: https://www.growthplusreports.com/report/fibroblast-growth-factor-receptor-inhibitor-market/8933 This latest report
Global Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) Market Forecast 2023- …
The global Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) market research report helps target customers understand the important driving factors and future opportunities of the industry. The report includes the dynamics of the macro environment such as the latest situation of the war between Russia and Ukraine, the update of monetary policy, and the impact of inflation on the market. Apart from this, the report studies key market developments such as
Avionic and electronic component corrosion inhibitor
Super CORR A was originally developed for the U.S. Air Force to comply with Mil-DTL-87177B (formerly Mil-L-87177A) specifications. A water displacing lubricant and corrosion protection compound that prevents avionic as well as electrical and electronic components from systems failures caused by corrosion. It is now the industry standard for electrical corrosion protection, for in service maintenance by both military and commercial aircraft major repair and overhaul (MRO) facilities worldwide. Super CORR